In the present report, submitted pursuant to General Assembly resolution 48/141, the United Nations High Commissioner for Human Rights outlines challenges in relation to access to medicines that arise in the existing system for pharmaceutical innovation, its associated business models and current pricing practices.

The Group of Independent Eminent Experts on the Implementation of the Durban Declaration and Programme of Action held its seventh session, in private and virtually, on 26 October 2021, The Group was...